Intermittent Fasting

What is Intermittent Fasting?

Intermittent fasting is a dietary approach that has gained significant attention in recent years and is even recommended by some experts. It involves restricting food intake during specific time intervals with the goal of enhancing fat metabolism. Its growing popularity is largely due to promising evidence suggesting a role in improving metabolic syndrome, a cluster of conditions characterized by obesity, insulin resistance, elevated triglycerides, and high cholesterol.

Unlike traditional calorie-restriction diets, intermittent fasting is defined not only by what is consumed but also when. Foods are eaten during predetermined time windows, while little to no calories are consumed outside of these periods, which may range from 12 hours to several days. Several approaches to intermittent fasting exist, including:

• Alternate-day fasting (24-hour fasts)

• The 5:2 method (normal intake five days per week, with very low or no intake on two days)

• Time-restricted feeding (e.g., consuming one or two meals within a narrow eating window, fasting for the remainder of the day).

As with all fat-loss strategies, intermittent fasting is effective only when a caloric deficit is maintained. However, studies suggest that intermittent fasting may make this deficit easier to sustain by reducing appetite and improving satiety.

The Physiology of Intermittent Fasting

The primary objective of fasting is to induce metabolic shifts in the body. The feeding-fasting cycle consists of four stages:

1. Feeding phase

2. Postprandial digestion phase

3. Fasting phase

4. Starvation phase

Glucose is the body’s principal energy source. After meals, glucose is used by the muscles, organs, and brain, while excess glucose is stored: first as glycogen in the liver and muscles, and when these stores are saturated, as triglycerides in adipose tissue. During prolonged fasting, insulin levels drop and glucagon secretion increases, mobilizing energy reserves. Glycogen is rapidly broken down into glucose due to its simple polymer structure, but as glycogen stores deplete, the body increasingly relies on fat. Triglycerides are broken into fatty acids and glycerol; fatty acids are converted in the liver into ketone bodies, which serve as alternative energy substrates.

Studies comparing dietary routines show that frequent meals keep ketone levels consistently low, whereas alternate-day fasting or 5:2 diets cause marked rises in ketone concentrations. Daily 18-hour fasting also elevates ketones, though less dramatically.

On a cellular level, intermittent fasting triggers pathways that enhance homeostasis, the body’s ability to adapt to stress and maintain balance. Energy-sensing mechanisms, including AMP-activated protein kinase (AMPK), signal cells to shift from anabolic (building) to catabolic (breaking down) states. This induces autophagy, a process in which cells recycle damaged proteins and organelles while improving mitochondrial function. In animal models, this has been linked to extended lifespan and improved health. However, there is insufficient human evidence to confirm whether intermittent fasting prolongs lifespan.

Intermittent Fasting and Weight Loss

Weight reduction occurs only through a caloric deficit, achieved either by reducing intake, increasing expenditure, or both. Visceral adipose tissue, particularly around the organs, secretes hormones such as leptin and adiponectin, which regulate appetite, inflammation, and energy metabolism. Studies indicate that intermittent fasting preferentially reduces visceral fat, thereby improving leptin and adiponectin balance and enhancing appetite control.

A 2017 clinical trial by Trepanowski et al. compared alternate-day fasting with traditional daily calorie restriction in obese individuals. Participants were divided into three groups:

• Alternate-day fasting: consumed 25% of caloric needs one day and 125% the next.

• Daily restriction: consumed 75% of caloric needs evenly each day.

• Control: no dietary changes.

After 12 months, the control group showed no weight change. Both fasting and calorie-restricted groups achieved ~7% weight loss at six months, with no significant difference between methods. Notably, dropout rates were higher in the fasting group, suggesting that long-term adherence may be more difficult.

Intermittent Fasting and Insulin Resistance / Diabetes

Intermittent fasting may improve insulin resistance through two mechanisms:

1. By reducing adiposity and chronic inflammation, which are major drivers of insulin resistance.

2. By lowering overall insulin secretion during fasting and increasing AMPK activity, thereby enhancing cellular insulin sensitivity.

In a study by Halberg et al., eight healthy men (mean BMI 25.7) followed an alternate-day fasting protocol, fasting for 20 hours every other day for two weeks while maintaining physical activity. Despite no significant weight loss, insulin sensitivity improved significantly. This supports the hypothesis that intermittent fasting may enhance insulin action independent of weight change.

GIR(Glucose Infusion Rate)

Considerations and Potential Risks

While intermittent fasting has promising benefits, it is not free of risks. Reported side effects include hypoglycemia, dizziness, and fatigue, which can be particularly dangerous in individuals on antidiabetic medications or in the elderly, where falls and fractures are a concern.

Adequate protein intake is another challenge. Because feeding windows are shortened, meeting daily protein requirements—especially for individuals engaged in fitness or bodybuilding—can be more difficult, potentially leading to muscle loss.

Intermittent fasting is not recommended for individuals with hormonal imbalances, pregnant or breastfeeding women, children and adolescents, elderly individuals, immunocompromised patients, those with eating disorders, or patients with dementia.

Conclusion

Intermittent fasting shows promise in promoting weight loss, reducing insulin resistance, and potentially lowering the risk of obesity-related conditions such as hypertension and cardiovascular disease. However, while animal studies strongly support additional benefits such as longevity, human studies to date have not demonstrated clear superiority over conventional calorie restriction. More high-quality clinical trials are needed to establish its long-term effects.

Reference

Vasim I, Majeed CN, DeBoer MD. Intermittent Fasting and Metabolic Health. Nutrients. 2022 Jan 31;14(3):631. doi: 10.3390/nu14030631. PMID: 35276989; PMCID: PMC8839325. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8839325/